Welcome to Nordic Society of Gynaecological Oncology

Collaborating Partner

Study documentation (link to documents, only accessible with password to www.nsgo.org).

Click HERE for access.

Study sponsorNSGO
NSGO Project ManagerDorte Nørvang
NSGO, Rigshospitalet, Copenhagen Denmark.
Email: Dorte.noervang@regionh.dk
+45 35 33 11
Study chair

Mansoor Mirza, NSGO, Rigshospitalet Copenhagen, Denmark

Mansoor.raza.mirza@regionh.dk

+45 3545 3939

Drug Durvalumab and MEDI9447
Phase II
Randomized trial No
Type Open label
Total number of patients 25
Number of patients recruitedTrial not open
Trial status 
Date of first site activatedMarch 2018
eCRFOpen Clinica test (protected information – access only with login)
Open Clinica Live ( protected information – access only with login)
Site listSite list – Not available. Will be added soon.
Protocol summaryNot available. Will be added soon.